Effect of Sugammadex in Wakeup Procedure

Trial Profile

Effect of Sugammadex in Wakeup Procedure

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Oct 2017

At a glance

  • Drugs Sugammadex (Primary) ; Neostigmine
  • Indications Neuromuscular blockade
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Sep 2016 Status changed from recruiting to completed.
    • 21 Jun 2016 Planned primary completion date changed from 1 May 2016 to 1 Jul 2016.
    • 25 Nov 2015 Planned end date changed from 1 Oct 2015 to 1 Jul 2016, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top